[FATE] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -13.34%
YoY- -58.56%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 5,465 2,515 2,802 2,429 2,817 2,632 1,661 121.37%
PBT -28,072 -33,520 -28,302 -26,609 -23,478 -19,760 -16,027 45.35%
Tax 635 0 691 910 1,015 1,091 817 -15.47%
NP -28,072 -33,520 -28,302 -26,609 -23,478 -19,760 -16,027 45.35%
Tax Rate - - - - - - - -
Total Cost 33,537 36,035 31,104 29,038 26,295 22,392 17,688 53.24%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -513.67 -1,332.80 -1,010.06 -1,095.47 -833.44 -750.76 -964.90 -34.33%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.35 -0.44 -0.37 -0.40 -0.36 -0.30 -0.25 25.17%
EPS Diluted -0.35 -0.44 -0.37 -0.40 -0.36 -0.30 -0.25 25.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.